HomeTagsPharmaceuticals

Pharmaceuticals

Flamingo-01 Breast Cancer Trial: Expanding the Reach of GLSI-100

Greenwich LifeSciences has shared important updates on the phase 3 Flamingo-01 trial, which is researching GLSI-100, a new immunotherapy for patients with a specific...

Carrick Therapeutics Launches Breast Cancer Trial for Novel Drug Combo

Carrick Therapeutics, a company focused on creating new cancer treatments, has recently started a significant study (Phase 1b/2 clinical trial) to test a combination...

Olaparib Study Cites Manageable Side Effects, No Lasting Quality of Life Impact

A recent clinical trial investigated olaparib's effects on patients with HER2-negative, BRCA-mutated early breast cancer, focusing on fatigue. Results showed temporary tiredness and nausea...

Advancements in HER2-Positive Breast Cancer: New Treatments Promise Improved Survival

Today we wanted to point to an outstanding interview with Dr. Nicholas P. McAndrew, an expert in breast cancer treatment. He recently shared insights on...

Continued Trial of Trilaciclib Shows Promise in Extending Survival for Triple-Negative Breast Cancer

The next phase of an important trial for metastatic triple-negative breast cancer patients is evaluating the effectiveness of trilaciclib combined with chemotherapy. This effort, officially...

Hot Topics